
    
      This will be an open label, randomized, single dose, 2-treatment, 2-period crossover study in
      healthy volunteers.Study treatments will be administered under fasting conditions.

      Blood samples for the analysis of tacrolimus in blood will be obtained as follows:
      Predose(immediately prior to dosing), and at 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 3, 4, 6,
      8, 12, 24, 48, 72 and 96 hours postdose.
    
  